An inhibitor of the epidermal growth factor receptor function does not affect the ability of human papillomavirus 11 to form warts in the xenografted immunodeficient mouse model

Antiviral Research

Volumn 74, Issue 1, 2007, Pages 43-50

  Parkinson, Tanya ^a   Howett, Mary K ^b   Welsh, Patricia A ^b   Patrick, Susan D ^b   Neely, Elizabeth B ^b   Flanagan, Neil ^a   Pollack, Vincent A ^c   Pustilnik, Leslie R ^c   Moyer, Jim ^c   Perros, Manos ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

EGFR; Epidermal growth factor; HPV; Papillomavirus

Indexed keywords

3 ETHYNYLPHENYL[7 METHOXY 6 (3 MORPHOLIN 4 YL PROPOXY)QUINAZOLIN 4 YL]AMINE; CP 545130; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG MECHANISM; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN TISSUE; IMMUNE DEFICIENCY; INHIBITION KINETICS; MORPHOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; PREPUCE; PRIORITY JOURNAL; VERRUCA VULGARIS; VIRUS REPLICATION; XENOGRAFT;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANIMALS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; HUMAN PAPILLOMAVIRUS 11; HUMANS; IMMUNOCOMPROMISED HOST; MICE; MICE, INBRED BALB C; MICE, NUDE; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSPLANTATION, HETEROLOGOUS; TUMOR VIRUS INFECTIONS; VIRUS REPLICATION; WARTS;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 11; MUS; PAPILLOMAVIRIDAE;

EID: 33847623236     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.12.004     Document Type: Article

References (26)

1. Akerman G.S., Tolleson W.H., Brown K.L., Zyzak L.L., Mourateva E., Engin T.S.W., Basaraba A., Coker A.L., Creek K.E., and Pirisi L. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes. Cancer Res. 61 (2001) 3837-3843
2. Arnold, L.D., Schnur, R.C., 1996. Novel anti-proliferative quinazoline derivatives useful for treating tumors, inflammatory disorders, etc. World Patent Application No. WO9630347.
3. Ben-Bassat H., Rosenbaum-Mitrani S., Hartzstark Z., Shlomai Z., Kleinberger-Doron N., Gazit A., Plowman G., Levitzki R., Tsvieli R., and Levitzki A. Inhibitors of epidermal growth factor receptor kinase and of cyclin-dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papillomavirus 16-immortalized human keratinocytes. Cancer Res. 57 (1997) 3741-3750
4. Conrad M., Goldstein D., Andresson T., and Schlegel R. The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors. Virology 200 (1994) 796-800
5. Crusius K., Auvinen E., and Alonso A. Enhancement of EGF- amd PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein. Oncogene 15 (1997) 1437-1444
6. Crusius K., Auvinen E., Steuer B., Gaissert H., and Alonso A. The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT. Exp. Cell Res. 241 (1998) 76-83
7. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351 (2000) 95-105
8. Howett M.K., Christensen N.D., and Kreider J.W. Tissue xenografts as a model system for study of the pathogenesis of papillomaviruses. Clin. Dermatol. 15 (1997) 229-236
9. Howley P.M. Papillomavirinae and their replication. In: Fields B.N., and Knipe D.M. (Eds). Fundamental Virology. third ed. (1996), Raven Press, New York, N.Y. 947-978
10. Johnston D., Hall H., DiLorenzo T.P., and Steinberg B.M. Elevation of the epidermal growth factor receptor and dependent signaling in human papillomavirus-infected laryngeal papillomas. Cancer Res. 59 (1999) 968-974
11. Kreider J.W., Howett M.K., Wolfe S.A., Bartlett G.L., Zaino R.J., Sedlacek T.V., and Mortel R. Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata. Nature 317 (1985) 639-641
12. Kreider J.W., Howett M.K., Lill N.L., Bartlett G.L., Zaino R.J., Sedlacek T.V., and Mortel R. In vivo transformation of human skin with human papillomavirus type 11 from condylomata acuminata. J. Virol. 59 (1986) 369-376
13. Lopez-Ocejo O., Viloria-Petit A., Bequet-Romero M., Mukhopadhyay D., Rak J., and Kerbel R.S. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. Oncogene 19 (2000) 4611-4620
14. Moyer J.D., Barbacci E.G., Iwata K.K., Arnold L., Boman B., Cunningham A., DiOrio C., Doty J., Morin M.J., Moyer M.P., Neveu M., Pollack V.A., Pustilnik L.R., Reynolds M.M., Sloan D., Theleman A., and Miller P. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res. 57 (1997) 4838-4848
15. Ozanne B., Richards C.S., Hendlen R., Burns D., and Gusterson B. Over-expression of the EGF receptor is a hallmark of squamous cell carcinoma. J. Pathol. 149 (1986) 9-14
16. Pollack V.A., Savage D.M., Baker D.A., Tsaparikos K.E., Sloan D.E., Moyer J.D., Barbacci E.G., Pustilnik L.R., Smolarek T.A., Davis J.A., Vaidya M.P., Arnold L.D., Doty J.L., Iwata K.K., and Morin M.J. Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358, 774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice. J. Pharmacol. Exp. Ther. 291 (1999) 739-748
17. Sizemore N., and Rorke E.A. Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor expression. Cancer Res. 53 (1993) 4511-4517
18. Stoler M.H., Whitbeck A., Wolinsky S.M., Broker T.R., Chow L.T., Howett M.K., and Kreider J.W. Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice. J. Virol. 64 (1990) 3310-3318
19. Straight S.W., Hinkle P.M., Jewers R.J., and McCance D.J. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 67 (1993) 4521-4532
20. Tomakidi P., Cheng H., Kohl A., Komposch G., and Alonso A. Modulation of the epidermal growth factor receptor by the human papillomavirus type 16 E5 protein in raft cultures of human keratinocytes. Eur. J. Cell Biol. 79 (2000) 407-412
21. Unger E.R., Hammer M.L., and Chenggis M.L. Comparison of 35S and biotin as labels for in situ hydridization: use of an HPV model system. J. Histochem. Cytochem. 39 (1991) 145-150
22. Vambutas A., Di Lorenzo T.P., and Steinberg B.M. Laryngeal papilloma cells have high levels of epidermal growth factor receptor and respond to epidermal growth factor by a decrease in epithelial differentiation. Cancer Res. 53 (1993) 910-914
23. Venuti A., Salani D., Cirilli A., Simeone P., Muller A., Flamini S., Padley R., and Bagnato A. Endothelin receptor blockade inhibits the growth of human papillomavirus-associated cervical carcinoma. Clin. Sci. 103 Suppl. 48 (2002) 310S-313S
24. Walker F., Kermorgan S., Darai E., Madelenat P., Cremieux A.C., Henin D., and Lehy T. Hepatocyte growth factor and c-Met in cervical intraepithelial neoplasia: overexpression of proteins associated with oncogenic human papillomavirus and human immunodeficiency virus. Clin. Cancer Res. 9 (2003) 273-284
25. Wilding J., Vousden K.H., Soutter W.P., McCrea P.D., Del Buono R., and Pignatelli M. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes. Cancer Res. 56 (1996) 5285-5292
26. Woodworth C.D., Gaiotti D., Michael E., Hansen L., and Nees M. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes. Cancer Res. 60 (2000) 4397-4402